It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:
Image Source: Getty Images
Catapult Sports Ltd (ASX: CAT)
According to a note out of Bell Potter, its analysts have retained their buy rating on this sports technology company's shares with a trimmed price target of $4.85. The broker has named Catapult as one of its preferred tech stocks amongst the mid caps. It highlights that the company is exposed to the pro sports technology market which was valued at US$36 billion in 2025 and is forecast to double to US$72 billion by 2030. In addition, the broker doesn't believe that AI is going to disrupt its business. Overall, if tech stocks rally, Bell Potter would expect Catapult to follow suit and be one of the better performers. This is because it believes there is a lack of other good quality tech stocks in the mid cap space. One slight negative is the potential for its shares to be kicked out of the ASX 200 index at the next rebalance. However, it believes this is largely priced in now. The Catapult share price is trading at $3.95 on Friday afternoon.
Life360 Inc (ASX: 360)
A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $50.00 price target on this family safety technology company's shares. The broker believes that Life360 is well-placed for strong long-term growth. It also highlights that the Life360 platform has defensive qualities and generates proprietary data from its user base of almost 100 million people. In light of this, it feels it would be difficult for AI to disrupt or replace the company's business model. The Life360 share price is fetching $22.01 at the time of writing.
Nufarm Ltd (ASX: NUF)
Another note out of Bell Potter reveals that its analysts have retained their buy rating and $3.60 price target on this agricultural chemicals company's shares. The broker has been looking at industry data and believes it is favourable. As a result, it expects Nufarm's upcoming half-year results to demonstrate a continuation of the margin recovery story that became evident last year in the crop protection business. It is also anticipating a material turnaround in omega-3 earnings based on improved pricing indicators. So, with its shares trading at 6x forward EBITDA, compared to 8x for peers, Bell Potter sees a lot of value on offer here. The Nufarm share price is trading at $2.11 this afternoon.
